LINE

    Text:AAAPrint
    Sci-tech

    American drugmaker launches phase 3 trial to test antibody treatment in U.S. nursing homes

    1
    2020-08-04 08:18:44Xinhua Editor : Li Yan ECNS App Download
    A man passes by the Isabella Geriatric Center in New York, the United States, May 3, 2020. (Photo by Michael Nagle/Xinhua)

    A man passes by the Isabella Geriatric Center in New York, the United States, May 3, 2020. (Photo by Michael Nagle/Xinhua)

    Special: Battle Against Novel Coronavirus

    American pharmaceutical firm Eli Lilly and Company on Monday announced the start of its phase 3 trial to study whether one of its experimental COVID-19 antibody treatments can prevent the virus infection in residents and staff at U.S. long-term care facilities.

    LY-CoV555, the lead antibody from Lilly's collaboration with Canadian biotech AbCellera, is a neutralizing antibody against SARS-CoV-2, the virus that causes COVID-19.

    More than 40 percent of coronavirus deaths in the United States linked to long-term care facilities, which creates the urgent need for therapies to prevent COVID-19 in this vulnerable population, Eli Lilly and Company said in a release.

    The first-of-its-kind study is expected to enroll up to 2,400 participants who live or work at facilities that have had a recently diagnosed case of COVID-19 and who are now at a high risk of exposure.

    It will evaluate the efficacy and safety of LY-CoV555 for the prevention of SARS-CoV-2 infection and COVID-19, testing whether a single dose of LY-CoV555 reduces the rate of SARS-CoV-2 infection through 4 weeks, as well as complications of COVID-19 through 8 weeks, said the company.

    "COVID-19 has had a devastating impact on nursing home residents," said Daniel Skovronsky, Lilly's chief scientific officer and president of Lilly Research Laboratories, in a statement. "We're working as fast as we can to create medicines that might stop the spread of the virus to these vulnerable individuals." 

    MorePhoto

    Most popular in 24h

    MoreTop news

    MoreVideo

    LINE
    Back to top Links | About Us | Jobs | Contact Us | Privacy Policy
    Copyright ©1999-2020 Chinanews.com. All rights reserved.
    Reproduction in whole or in part without permission is prohibited.
    主站蜘蛛池模板: 房产| 浦江县| 沙坪坝区| 成都市| 渑池县| 湟中县| 台湾省| 盘锦市| 阿拉尔市| 新泰市| 澄城县| 仙居县| 黄梅县| 万盛区| 红原县| 新兴县| 广宁县| 白河县| 汉川市| 咸丰县| 磐石市| 都安| 桂平市| 潢川县| 临猗县| 叙永县| 南宫市| 岑巩县| 长岭县| 凤冈县| 寻甸| 枣阳市| 望谟县| 环江| 怀化市| 宾川县| 湟中县| 天祝| 沁水县| 栾川县| 通山县|